Covid-19 second wave in Mumbai, India.
We fill gaps in India’s health system and provide specific medical care to neglected people who would otherwise struggle to access it.

We have a number of long-standing projects in India, which we run in conjunction with the state authorities to address specific healthcare needs and emerging public health concerns.

We also run mobile clinics in remote areas of the country, where even preventable, treatable conditions such as malaria can assume life-threatening proportions.

Our teams are currently responding to the coronavirus COVID-19 pandemic in the country.

Key Activities

Our activities in 2020 in India

Data and information from the International Activity Report 2020.

MSF in India in 2020 India is a country of vast size and inequality, with considerable disparity in the level of medical treatment available, depending on a person’s income and where they live.
Map of MSF activities in 2020 in India

MSF works to fill some of the gaps in services for the most marginalised communities, including mental health support in hospitals in four districts of Kashmir. We also treat victims of sexual and gender-based violence in our clinic in New Delhi, where we provide round-the-clock, confidential services for people of all ages. When COVID-19 restrictions were imposed, we switched to phone-based counselling services and digital health promotion activities to guarantee continuity of care.

Treatment for infectious diseases
In our HIV centres in Manipur, we implement a model of care that is tailored to patients’ needs. We also support the antiretroviral treatment centre and inpatient management of HIV in a district hospital, and distribute food coupons and dry rations to homeless intravenous drug users.

MSF has been working with the government to increase access to holistic care for HIV patients with life-threatening opportunistic infections. In 2020, in Bihar, one of India’s poorest states, we focused on antimicrobial resistance stewardship to guide the prescribing and use of antibiotics. Palliative care, nutrition, mental health support and advocacy are also important components of our model of care.
In Mumbai, we continued to offer care for patients with drug-resistant tuberculosis (TB), with paediatric care a priority in 2020. The first patients were enrolled in the EndTB clinical trial using the new generation of drugs, aimed at finding shorter, more tolerable, injection-free treatments for multidrug-resistant TB.

Handing over projects
India has the world’s highest rate of childhood malnutrition, and in Jharkhand, one of the worst-affected states, MSF has contributed to shaping the treatment protocol. Although we discontinued our project providing community management of acute malnutrition in early 2020, we continued to follow up children with severe acute malnutrition discharged from the programme.

In 2020, we handed over to the health authorities the general healthcare services that we had been running via mobile clinics in the conflict-affected border areas of Andhra Pradesh, Chhattisgarh and Telangana states for 14 years.


In 2020
Kala azar-HIV co-infection in Bihar, Animated explainer | ENG

Explaining kala azar-HIV co-infection

Have you heard of kala azar?

Kala azar is a neglected but potentially fatal tropical disease. India accounts for 30 per cent of cases worldwide.

This short animation explains what kala azar is, how it relates to HIV, and what we are doing in response.

Since 80 per cent of India's kala azar cases are reported in Bihar, we set up a programme there in 2007.

People living with HIV are particularly vulnerable to kala azar, so since 2016 we have been focusing on treating patients co-infected with the two diseases, in partnership with the Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Bihar.

Activists from across Europe stage flashmob in front of the European Parliament
Project Update

EU-India free trade deal puts millions of lives at risk

Press Release 9 Apr 2013

Indian supreme court delivers verdict in Novartis case

Press Release 1 Apr 2013
FTA Protest Delhi - February 2012

Under pressure from Europe to sign off on trade deal that will harm access to medicines

Project Update 13 Mar 2013

Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug

Statement 18 Jan 2013

Double frontal attack on the 'pharmacy of the developing world'

Voices from the Field 17 Sep 2012

Novartis challenges pro-health patent law

Press Release 11 Sep 2012

Contact us

Treating kala azar-HIV co-infection in Bihar, India
MSF India

5th Floor, Okhla NSIC Metro Station Building
New Delhi – 110020